Madrigal Pharmaceuticals - Conshohocken, PA
posted 26 days ago
Madrigal is a biopharmaceutical company pursuing novel therapeutics for non-alcoholic steatohepatitis (NASH), also known as metabolic dysfunction associated steatohepatitis (MASH). Our first therapy, Rezdiffra (resmetirom), was granted accelerated approval by the U.S. Food and Drug Administration (FDA) for the treatment of adults with NASH with moderate to advanced liver fibrosis (consistent with stages F2 to F3 fibrosis) and is being studied in a Phase 3 trial for the treatment of NASH with compensated cirrhosis. We are seeking a highly motivated and experienced professional to join our team as the Director, Access and Reimbursement Manager. In this role, you will lead a national team of Access and Reimbursement Managers (ARMs) focused on supporting Healthcare Providers offices in optimizing patient access to a large pharmacy benefit specialty product. This role emphasizes leadership, strategic coaching, and operational excellence to deliver outstanding results in patient access and reimbursement.